Trexquant Investment’s KalVista Pharmaceuticals KALV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$144K Buy
2024
Q2
Sell
2024
Q1
$658K Buy
2022
Q3
Sell
2022
Q2
$384K Buy
2022
Q1
Sell
2021
Q4
$227K Sell
2021
Q3
$334K Buy
2020
Q3
Sell
2020
Q2
$159K Buy
2019
Q4
Sell
2019
Q3
$183K Buy